Level Four Advisory Services’s NeoGenomics NEO Stock Holding History

Level Four Advisory Services’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,733	Closed	-$414K	–	823
2023 Q2	$414K	Buy	+25,733	New	+$424K	0.02%	535
2021 Q1	–	Sell	-4,901	Closed	-$264K	–	651
2020 Q4	$264K	Buy	+4,901	New	+$221K	0.02%	501

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Level Four Advisory Services's NEO Position: Q3 2023 in Review

Level Four Advisory Services sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 25,733 shares — an estimated $414K sold.

Level Four Advisory Services first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $414K in Q2 2023. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

Level Four Advisory Services reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
Level Four Advisory Services sold 25,733 NeoGenomics shares in Q3 2023, an estimated $414K.
Level Four Advisory Services first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
Level Four Advisory Services's NeoGenomics position peaked at $414K in Q2 2023.
283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.